Pathological Response in a Triple Negative Breast Cancer Cohort Treated With Neoadjuvant Carboplatin and Docetaxel According to Lehmann's Refined Classification
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-17-1912
Full Text
Open PDFAbstract
Available in full text
Date
January 29, 2018
Authors
Publisher
American Association for Cancer Research (AACR)